Cosmo Pharmaceuticals N.V. (COPN.SW) - Stock Prices, Stock Peers & Analysis

Home
COPN.SW

Company Name	Cosmo Pharmaceuticals N.V.
Symbol	COPN.SW
Currency	CHF
Price	65.2
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	1,046,190,333
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	1.41%
52-week-range	36 - 80.6
Industry	Drug Manufacturers—General
Sector	Healthcare
CEO	Mr. Alessandro E. Della Cha LL.M
Website	https://www.cosmopharma.com

An error occurred while fetching data.

About Cosmo Pharmaceuticals N.V.

Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, an oral tablet formulation for remission in active, mild to moderate ulcerative colitis; GI Genius, a system that uses artificial intelligence to detect colorectal polyps; and